PedAM
Pediatric Disease Annotations & Medicines
| Disease | c syndrome |
| Phenotype | C0042373|vascular disease |
| Sentences | 82 |
| PubMedID- 23306779 | Moreover, vascular insulin resistance negatively impacts vascular health by affecting blood pressure regulation, vessel wall inflammation and atherogenesis thereby contributing to the burden of vascular disease seen with diabetes and metabolic syndrome. |
| PubMedID- 21130454 | Given the frequent concordance of metabolic diseases including diabetes, obesity, and metabolic syndrome with cardiovascular diseases associated with hyperlipidemia, it is important to understand the potential metabolic risks and benefits of therapies with distinct statins. |
| PubMedID- 20488778 | In any case, the results of the present study suggest that the endocrine disruptor bpa should be evaluated as a possible risk factor for gestational diabetes, type 2 diabetes, and cardiovascular disease associated with metabolic syndrome. |
| PubMedID- 20508159 | The hypothesis that rimonabant has protective effects against vascular disease associated with the metabolic syndrome was tested using jcr:la-cp rats. |
| PubMedID- 23257741 | [chronic cerebrovascular diseases associated with metabolic syndrome: new treatment approaches]. |
| PubMedID- 20349347 | The cardiovascular disease associated with the metabolic syndrome and with diabetes mellitus comprises vascular and myocardial abnormalities. |
| PubMedID- 23334870 | This study assesses the feasibility and efficacy of a multifactorial approach for primary prevention of cardiovascular disease risk assessment in patients with metabolic syndrome in the daily clinical practice setting. |
| PubMedID- 24624345 | Moreover, many epidemiological studies have suggested that hyperuricemia, which may be an independent risk factor for metabolic syndrome [4], is associated with kidney disease, cardiovascular disease [5], cerebrovascular disease [6], obesity, diabetes, hypertriglyceridemia, and hypertension. |
| PubMedID- 23677576 | Cancer risk in patients with manifest vascular disease: effects of smoking, obesity, and metabolic syndrome. |
| PubMedID- 21123363 | The metabolic syndrome is associated with elevated peripheral vascular disease risk, characterized by mismatched blood flow delivery/distribution and local metabolism. |
| PubMedID- 25957218 | Sustained release nitrite therapy results in myocardial protection in a porcine model of metabolic syndrome with peripheral vascular disease. |
| PubMedID- 22205060 | The worldwide obesity epidemic has brought to the author's attention the cardiometabolic risk factors and cardiovascular disease associated with the metabolic syndrome. |
| PubMedID- 22916265 | The higher risk of cardiovascular disease in patients with metabolic syndrome and hypertension could depend partly on the degree of sympathetic hyperactivity. |
| PubMedID- 22682107 | Background: to evaluate the importance of oral glucose tolerance test (ogtt) in predicting diabetes and cardiovascular disease in patients with and without metabolic syndrome from a population treated in a primary care unit. |
| PubMedID- 26552468 | Emerging evidence suggests that gout is strongly associated with metabolic syndrome and may lead to cardiovascular disease, diabetes, and premature death [11-14]. |
| PubMedID- 23936649 | The association of metabolic syndrome with cardiovascular disease was already observed more than 40 years ago [187]. |
| PubMedID- 21466628 | Based on the increased cardiovascular disease risk of the metabolic syndrome, which is similar to stage 1 hypertension, both lifestyle modification and arb therapy are justifiable. |
| PubMedID- 24788056 | The most common conditions for which genetic counseling was provided were hypertrophic cardiomyopathy (hcm) (71% of participants), dilated cardiomyopathy (dcm) (61%), long qt syndrome (lqts) (56%), and genetic syndromes with cardiovascular disease (55%). |
| PubMedID- 20004035 | Aims: to compare the cardiovascular disease (cvd) risk associated with the metabolic syndrome (mets) and dysglycemia, independent of each other during a median follow-up of 6.7 years. |
| PubMedID- 23873328 | Background and aims: metabolic syndrome (ms) leads to excess cardiovascular disease, including heart failure. |
| PubMedID- 20940070 | Analysis results on population attributable risks showed that about a quarter of total diabetes occurrence and more than 10% of cardiovascular disease was attributable to the metabolic syndrome. |
| PubMedID- 22417460 | High sensitivity c-reactive protein (hs-crp), a marker of systemic inflammation and a predictor of type 2 diabetes and cardiovascular disease, is associated with the metabolic syndrome and its separate components. |
| PubMedID- 20689417 | Recent findings: individuals infected with hiv frequently demonstrate a metabolic syndrome associated with atherosclerosis and cardiovascular disease. |
| PubMedID- 23130323 | Therefore, people with a high basal c-peptide level need to decrease it to reduce the risk of coronary heart disease and cerebral vascular disease associated with metabolic syndrome. |
| PubMedID- 25248654 | Studies linking low testosterone to the metabolic syndrome (with its sequelae cardiovascular disease and diabetes mellitus) and inflammation have been predominantly performed in elderly men. |
| PubMedID- 22123633 | There seems to be an inverse relation between 25(oh)d serum concentrations and cardiovascular diseases, some components of the metabolic syndrome, and physical fitness. |
| PubMedID- 22424625 | Objective: the association of metabolic syndrome (mets) with cardiovascular diseases (cvd) has not been adequately explored in middle-aged and elderly chinese. |
| PubMedID- 21808142 | Cd36 deficiency is related to phenotypic expression of the metabolic syndrome, frequently associated with atherosclerotic cardiovascular diseases resulting in raised levels of glucose thereby contributing to type 2 diabetes (t2dm). |
| PubMedID- 24498934 | Relation between ev-markers and metabolic syndrome in patients with manifest cardiovascular disease. |
| PubMedID- 25228949 | Furthermore, metabolic syndrome is associated with vascular diseases including ph. |
| PubMedID- 24396692 | Furthermore, nafld is emerging as a risk factor for diabetes and cardiovascular disease, independently of insulin resistance, metabolic syndrome, plasma lipid level, and other traditional risk factors [2]. |
| PubMedID- 23300705 | These risks include obesity and metabolic syndrome associated with cardiovascular disease. |
| PubMedID- 23199128 | In this review, we first describe the population trend in the degree of obesity as measured by the body mass index (bmi), and review prospective cohort studies that reported associations of obesity measures and metabolic syndrome (mets) with cardiovascular diseases (cvd) in japanese. |
| PubMedID- 25247821 | These findings have important public health implications due to the known cardiovascular disease risk factors associated with metabolic syndrome. |
| PubMedID- 21318102 | Increasing plasma apn or enhancing apn signal transduction may be an ideal strategy to prevent and treat the cardiovascular diseases associated with metabolic syndrome. |
| PubMedID- 25541285 | The insulin-like growth factor i system: physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome. |
| PubMedID- 21679922 | Microalbuminuria accounts for the increased risk of cardiovascular disease in patients with metabolic syndrome. |
| PubMedID- 22877354 | Data from a community based study was used to assess the risk for type 2 diabetes, cardiovascular disease and prevalence of metabolic syndrome in middle-aged men. |
| PubMedID- 24553695 | Dietary echium oil increases long-chain n-3 pufas, including docosapentaenoic acid, in blood fractions and alters biochemical markers for cardiovascular disease independently of age, sex, and metabolic syndrome. |
| PubMedID- 21845221 | Nafld is becoming a risk factor for diabetes and cardiovascular diseases (cvds) independently of insulin resistance, metabolic syndrome, plasma lipid levels, and other usual risk factors [3, 4]. |
| PubMedID- 20823276 | Aims: the adipokine visfatin, produced during obesity, has been reported to participate in the development of cardiovascular disease associated with metabolic syndrome. |
| PubMedID- 24844874 | Background: subclinical cardiovascular disease is prevalent in patients with metabolic syndrome (metsyn). |
| PubMedID- 22359422 | The metabolic syndrome among patients with cardiovascular disease in accra, ghana. |
| PubMedID- 26491696 | In particular, sodium reabsorption is regulated by various transporters along the nephron and to elucidate the mechanism of its regulation is important because excess renal sodium retention causes hypertension in metabolic syndrome that leads to cardiovascular disease [1]. |
| PubMedID- 19781706 | There is ample epidemiological evidence linking obesity, and the related ‘metabolic syndrome’, with vascular disease [1]. |
| PubMedID- 24819036 | Changes in concentration and several single-nucleotide polymorphisms (snp) at the gpx3 gene have been associated with vascular diseases, but the relationship of gpx3 with metabolic syndrome (mets) remains unexplored. |
| PubMedID- 21766575 | [the association of cardiovascular disease with metabolic syndrome and its risk factors in japanese urban cohort: the suita study]. |
| PubMedID- 24716162 | It is also strongly related to other pathological conditions, including obesity, diabetes, cardiovascular diseases, and symptoms of metabolic syndrome. |
| PubMedID- 25857370 | Background and purpose: increased level of very low-density lipoprotein (vldl) is a key feature of the metabolic syndrome and is associated with cardiovascular diseases. |
| PubMedID- 26485682 | Sympathetic abnormalities play an important role in the pathophysiology of cardiovascular disease associated with metabolic syndrome, diabetes mellitus and obesity [1–4]. |
Page: 1 2